DUBLIN – Ireland is entering the genomics era in earnest, on the back of a 15-year alliance between Genomics Medicine Ireland (GMI) Ltd., Abbvie Inc., and Wuxi Nextcode, under which GMI plans to sequence 45,000 genomes in order to uncover new therapeutic targets and pathways relevant to oncology, neuroscience and immunology.